TGM2 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome: Tissue transglutaminase (TG2) is implicated in regulation of cell attachment, interactions of the cells with the surrounding ECM, motility and invasion, and is considered as a bad prognostic factor in different cancers, including PaCa 27,33–35.